Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Regulatory PMS Study for Lucentis® in Patients With Retinopathy of Prematurity

Novartis Pharmaceuticals · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
koreanis
retinopathy of prematurity, nis, post-marketing surveillance, lucentis, ranibizumab, korea, observational
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 874169
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.